English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation

Swietlik, J. J., Barthel, S., Falcomata, C., Fink, D., Sinha, A., Cheng, J., et al. (2023). Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. Nature Communications, 14(1): 2642. doi:10.1038/s41467-023-38171-8.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Swietlik, Jonathan J.1, Author           
Barthel, Stefanie2, Author
Falcomata, Chiara2, Author
Fink, Diana2, Author
Sinha, Ankit3, Author           
Cheng, Jingyuan1, Author
Ebner, Stefan2, Author
Landgraf, Peter2, Author
Dieterich, Daniela C.2, Author
Daub, Henrik2, Author
Saur, Dieter2, Author
Meissner, Felix1, Author
Affiliations:
1Meissner, Felix / Experimental Systems Immunology, Max Planck Institute of Biochemistry, Max Planck Society, ou_2149678              
2external, ou_persistent22              
3Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565159              

Content

show
hide
Free keywords: TRANSFER-RNA SYNTHETASE; DUCTAL ADENOCARCINOMA; MACROPHAGE POLARIZATION; CLICK CHEMISTRY; LYSYL OXIDASE; IDENTIFICATION; METASTASIS; QUANTIFICATION; SPECIFICITY; ENRICHMENTScience & Technology - Other Topics;
 Abstract: "In-depth cell-selective proteomics and secretomics has remained challenging. Here, the authors devise an optimised azidonorleucine labelling, mass spectrometry method and detect over 10,000 proteins in a pancreatic ductal adenocarcinoma model.
Cell-selective proteomics is a powerful emerging concept to study heterocellular processes in tissues. However, its high potential to identify non-cell-autonomous disease mechanisms and biomarkers has been hindered by low proteome coverage. Here, we address this limitation and devise a comprehensive azidonorleucine labeling, click chemistry enrichment, and mass spectrometry-based proteomics and secretomics strategy to dissect aberrant signals in pancreatic ductal adenocarcinoma (PDAC). Our in-depth co-culture and in vivo analyses cover more than 10,000 cancer cell-derived proteins and reveal systematic differences between molecular PDAC subtypes. Secreted proteins, such as chemokines and EMT-promoting matrisome proteins, associated with distinct macrophage polarization and tumor stromal composition, differentiate classical and mesenchymal PDAC. Intriguingly, more than 1,600 cancer cell-derived proteins including cytokines and pre-metastatic niche formation-associated factors in mouse serum reflect tumor activity in circulation. Our findings highlight how cell-selective proteomics can accelerate the discovery of diagnostic markers and therapeutic targets in cancer.

Details

show
hide
Language(s): eng - English
 Dates: 2023-05-08
 Publication Status: Published online
 Pages: 17
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Nature Communications
  Abbreviation : Nat. Commun.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: London : Nature Publishing Group
Pages: - Volume / Issue: 14 (1) Sequence Number: 2642 Start / End Page: - Identifier: ISSN: 2041-1723
CoNE: https://pure.mpg.de/cone/journals/resource/2041-1723